How to buy Eli Lilly and Company shares

Eli Lilly and Company shares have increased 0.42% from their previous closing price ($774.9). Learn how to easily invest in Eli Lilly and Company shares in the UK.

Eli Lilly and Company (LLY) is a publicly traded drug manufacturers - general business based in the US which employs around 43,000 staff. Eli Lilly and Company is listed on the NYSE and traded in US dollars. Its current price of $778.18 is 1.7% up on its price a month ago ($765).

How to buy shares in Eli Lilly and Company

  1. Choose a platform. If you're a beginner, our share trading platform picks below can help you choose.
  2. Open your account. Provide your personal information and sign up.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: LLY in this case.
  5. Research shares. The platform should provide the latest information available.
  6. Buy your shares. Place a market order or limit order with your preferred number of shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy Eli Lilly and Company shares

Best for 0% commission stocks

Finder Award
Go to site
Capital at risk. Other fees apply.
Copy picks from top traders
  • Commission-free stock trades
  • Receive dividend payments
  • Invest in fractional shares

Best for fractional shares

Go to site
Capital at risk. T&Cs apply.
Personalised market updates
  • Commission-free trading
  • Invest in fractional shares
  • Over 5,400 stocks & ETFs

Best for customer satisfaction

Finder Award
Go to site
Capital at risk. T&Cs apply.
97% would recommend
  • No commissions for funds
  • Expert research and insights
  • Wide range of tax wrappers

Fees calculator for buying Eli Lilly and Company shares with popular apps

Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.

Quantity of shares

1
Platform Finder score Account fee Min. initial deposit Trade cost Link
eToro Free Stocks logo
4.39/5 ★★★★★
£0 $100 £619.95
Go to siteCapital at risk
XTB logo
4.3/5 ★★★★★
£0 £0 £619.95
Go to siteCapital at risk
Hargreaves Lansdown Fund and Share Account logo
4.2/5 ★★★★★
£0 £1 £634.98
Go to siteCapital at risk
CMC Invest share dealing account logo
4.38/5 ★★★★★
£0 £0 £619.95
Read reviewCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Alternative ways to invest in Eli Lilly and Company

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Eli Lilly and Company), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

Eli Lilly and Company is a major part of the NYSE, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

Is it a good time to buy Eli Lilly and Company stock?

Only you can make the decision on the time to leap... but here's some supporting information and analysis.

Use our graph to track the performance of LLY stocks over time.

Share price volatility

Over the last 12 months, Eli Lilly and Company's shares have ranged in value from as little as $320.5764 up to $800.78. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Eli Lilly and Company's is 0.344. This would suggest that Eli Lilly and Company's shares are less volatile than average (for this exchange).

Historical closes compared with the last close of $778.18

1 week (2024-03-19)0.69%
1 month (2024-02-26)1.72%
3 months (2023-12-26)33.82%
6 months (2023-09-26)41.55%
1 year (2023-03-26)132.57%
2 years (2022-03-24)169.25%
3 years (2021-03-25)319.93%
5 years (2019-03-26)504.32%

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks
Invest in Eli Lilly and Company shares
Finder Award
  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Eli Lilly and Company under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Eli Lilly and Company P/E ratio, PEG ratio and EBITDA

Eli Lilly and Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 133x. In other words, Eli Lilly and Company shares trade at around 133x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Eli Lilly and Company's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.

Eli Lilly and Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4631. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Eli Lilly and Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Eli Lilly and Company's PEG ratio in relation to those of similar companies.

Eli Lilly and Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $12.3 billion (£9.8 billion).

The EBITDA is a measure of a Eli Lilly and Company's overall financial performance and is widely used to measure a its profitability.

To put that into context you can compare it against similar companies.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

  • How to buy Canopy Growth shares

    Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.

  • How to buy Green Thumb Industries shares

    Ever wondered how to buy shares in Green Thumb Industries? We explain how and compare a range of providers that can give you access to many brands, including Green Thumb Industries.

  • How to buy Curaleaf Holdings shares

    Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.

  • How to buy Genesis Healthcare shares

    Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.

  • How to buy Allergy Therapeutics shares

    Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.

  • How to buy 4D pharma shares

    Ever wondered how to buy shares in 4D pharma? We explain how and compare a range of providers that can give you access to many brands, including 4D pharma.

  • How to buy Aurora Cannabis shares

    Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.

  • How to buy Evgen Pharma shares

    Thinking about buying shares in Evgen Pharma? We explain how to do it and compare a range of providers who will give you access to global markets.

  • How to buy Intuitive Surgical shares

    Ever wondered how to buy shares in Intuitive Surgical? We explain how and compare a range of providers that can give you access to many brands, including Intuitive Surgical.

  • How to buy Stryker Corporation shares

    Ever wondered how to buy shares in Stryker? We explain how and compare a range of providers that can give you access to many brands, including Stryker.

Go to site